Found 0 matching trials
Exjade-Early-Trial
PHASE2Study outline: Deferasirox (Exjade®) is regularly used in severe iron overl...
Location
Medizinische Klinik 5, Universitätsklinikum Erlangen
Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies
PHASE2RATIONALE: Deferasirox may remove excess iron from the body caused by blood...
Location
Comprehensive Cancer Center of Wake Forest University
Efficacy and Safety Study of Deferasirox in Patients With Non-transfusion Dependent Thalassemia
PHASE4Assessed the efficacy of deferasirox in patients with non-transfusion depen...
Location
Novartis Investigative Site
Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias
PHASE2The purpose of this study is to determine the effects of the oral iron chel...
Location
Children's Hospital Oakland
Evaluation of the Quality of Life in Patients With Chronic Iron Overload Due to Hemoglobinopathies in Greece.
N/AThis observational clinical study aims to evaluate the HRQoL of thalassemia...
Location
Multiple Locations
Open-Label Single-Arm Pilot Study in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients With Transfusional Iron Overload
PHASE4This study has been designed to establish the efficacy and safety of defera...
Location
Novartis Investigative Site
Endocrine Function During Deferasirox Therapy
N/AA national survey on the prevalence and natural history of endocrine compli...
Location
Università degli Studi della Campania Luigi Vanvitelli
Quality of Life and Treatment Satisfaction in β-Thalassemia Patients Receiving Deferasirox
N/ARegular blood transfusions are essential for the management of haematologic...
Location
Assiut University Hospital
Comparison of Deferasirox and Desferoxamine in Patients of β-Thalassemia Major With Iron Overload
NAThis study was planned to compare deferasirox and desferrioxamine in terms ...
Location
Thalassemia Center of Hematology Department, The Children's Hospital & The Institute of Child Health
Amlodipine as Adjuvant Treatment to Iron Chelation for Prevention of Cardiac Iron Overload in Thalassemia Patients
NAThis is a randomized, open label, two arms superiority trial of a represent...
Location
University Health Network